Related Experiment Video
Updated: Jan 27, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Remote Monitoring of Patient-Reported Outcomes in Ulcerative Colitis: A Prospective Real-World Pilot Study.
Shaji Sebastian1, Jenna Roberts2, John Waller2
1IBD Unit, Hull and East Yorkshire Hospital NHS Trust, Hull, UK.
Remote online reporting of patient-reported outcomes (PRO2) for ulcerative colitis (UC) symptoms was feasible. This method showed high patient adherence and could support frequent symptom assessment without increasing healthcare burden.
Area of Science:
- Gastroenterology and Hepatology
- Digital Health and Telemedicine
- Clinical Trial Methodology
Background:
- The 6-point Mayo score for ulcerative colitis (UC) utilizes two patient-reported outcomes (PRO2): stool frequency and rectal bleeding.
- Assessing the feasibility and acceptability of remote online PRO2 reporting is crucial for golimumab-treated UC patients.
Purpose of the Study:
- To evaluate the feasibility and acceptability of remote online PRO2 reporting in patients with ulcerative colitis (UC) receiving golimumab treatment.
- To assess patient adherence and satisfaction with a digital platform for symptom monitoring.
Main Methods:
- A UK-based, multi-centre, prospective, real-world, non-interventional pilot study.
- 52 UC patients completed PRO2 scores online every 4 weeks for 6 months.
- Anonymized data collection via an online platform, including demographics and a satisfaction questionnaire.
Main Results:
- High patient engagement: 90% completed baseline, with subsequent reporting success rates between 81-94% over 6 months.
- Diverse device usage: Patients utilized personal computers (44%), mobile phones (38%), and tablets (18%).
- Low attrition rates observed among patients initially willing to participate.
Conclusions:
- Remote online monitoring of PRO2 is feasible for UC patients treated with golimumab.
- The system demonstrated high patient adherence and could facilitate more frequent symptom assessments.
- This approach offers a potential solution to support symptom monitoring without overburdening healthcare resources.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Pilot and Numeric Relaying
Data Reporting and Recording
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Predicting Reaction Outcomes

